Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.
OBJECTIVES: To estimate the times from HIV seroconversion to death, and to the initiation of therapy and the mean CD4 cell count at initiation. DESIGN AND METHODS: Using Kaplan-Meier methods, allowing for late entry, we analysed CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europ...
Main Author: | CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe) Collaboration |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?
by: Concerted Action on SeroConversion to AIDS and Death in Europe (CASCADE Collaboration)
Published: (2001) -
Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.
by: CASCADE Collaboration
Published: (2003) -
THE INFLUENCE OF HIV INFECTION DURATION BEFORE ANTIRETROVIRAL THERAPY ON IMMUNOLOGICAL TREATMENT FAILURE
by: A. F. Oleynik, et al.
Published: (2017-06-01) -
Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates.
by: Touloumi, G, et al.
Published: (2004) -
Influence of the duration of antiretroviral use on insulin resistance among people living with HIV with lipodystrophy
by: Thiago Rodrigues Faria Vitorazzi, et al.
Published: (2018-12-01)